{"id":10909,"date":"2009-06-26T00:00:00","date_gmt":"2009-06-26T00:00:00","guid":{"rendered":""},"modified":"-0001-11-30T00:00:00","modified_gmt":"-0001-11-30T04:00:00","slug":"cuddling-up-to-bdsi","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/06\/2009\/cuddling-up-to-bdsi.html","title":{"rendered":"Cuddling Up to BDSI"},"content":{"rendered":"<p>Triangle Business Journal &#8211; As <span class=\"story_clink\">BioDelivery Sciences International<\/span> awaits approval of its first product, a New York hedge fund has gained control of enough BDSI shares to become its largest shareholder.  <\/p>\n<p>With what looks like one goal in mind &ndash; making a lot of money.<\/p>\n<p><span class=\"story_clink\">Elliott International Capital Advisors<\/span> is the same firm that tried to shake up Raleigh-based BDSI with a management change two years ago. That was at a time when the company was developing Onsolis, a small disk placed on the inside of the cheek that quickly delivers the drug fentanyl to cancer patients suffering breakthrough pain.<\/p>\n<p>  <strong><a target=\"_blank\" href=\"http:\/\/www.hedgeco.net\/news\/news_land.php?i=http:\/\/triangle.bizjournals.com\/triangle\/stories\/2009\/06\/29\/story1.html?b=1246248000^1851516\">Read Complete Article<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Triangle Business Journal &#8211; As BioDelivery Sciences International awaits approval of its first product, a New York hedge fund has gained control of enough BDSI shares to become its largest shareholder. With what looks like one goal in mind &ndash; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[13574,13571,13573,13575,3203,13579,13578,13577,11148,13576,48,1099,13572],"class_list":["post-10909","post","type-post","status-publish","format-standard","hentry","category-syndicated","tag-bdsi","tag-biodelivery-sciences-international","tag-breakthrough-pain","tag-cancer-patients","tag-capital-advisors","tag-cheek","tag-fentanyl","tag-goal-in-mind","tag-hedge-fund","tag-management-change","tag-money","tag-shareholder","tag-triangle-business-journal"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/10909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=10909"}],"version-history":[{"count":0,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/10909\/revisions"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=10909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=10909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=10909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}